Replies to post #378001 on NorthWest Biotherapeutics Inc (NWBO)

[vator]

If you are anticipating TLD to be good sitting at a base over $2 is not unimaginable because with good data in a major publication it will jump out of sight quick. If you expect the data to stink, volume will dry up again and we will probably head lower.

Tough call. I think the data will be good. It is up to the new investors to see the value. If the vaccine ends up treating all solid cancers, $2 will be minuscule as it plays out.

[marzan]

There is news, plenty we saw; there will be plenty more from LP tomorrow, imo. She doesn't have to reveal or release TLD tomorrow; but if she says at the least that the 2018 JTM blinded data is still valid or still good, bingo, it implies what more is coming shortly at ASCO, imo. They might update the Sawston progress how close they are to UK approval, imo. Simply put, anything they say at this junction is going to be viewed very positive, imo. This stock should already trade $7+ now; name one therapy including the scam helmet in the past 20 yrs that gives the kind of survival benefit you saw in the 2018 JTM paper?

[WVUfollower]

I think the $1.50's are in the rearview mirror. We are going higher from here.